Chinese women join global breast cancer trial

Jul 30, 2009

Breast cancer patients have for the first time been recruited from China to take part in an international trial of breast radiotherapy.

Researchers will evaluate how effective the treatment is for women who have had a mastectomy.

Radiotherapy works by destroying in the treated area. The trial will investigate whether the treatment lessens the risk of the cancer returning in patients who have had a breast removed.

The results of the trial will be highly relevant in China, where is becoming a major health care issue, particularly in urban populations.

The trial represents the first time that international breast cancer research has included Chinese patients and opens the door to future collaborations.

Some 3700 breast cancer patients from Europe, Australia, Singapore, Japan and China will take part in the trial, led by the University of Edinburgh.

Chinese patients will be recruited from nine cancer centres across the country and will be randomly assigned one of two possible courses of treatment - one to include standard post-operative care such as outpatient visits and mammogram check-ups, and another, which includes all these treatments plus radiotherapy.

Researchers will be looking for a molecular finger print of each patient's cancer to try and identify patients most likely to benefit from .

Professor Ian Kunkler, from the Edinburgh Cancer Research Centre at the University of Edinburgh, said: "China is experiencing a rapidly rising incidence of breast cancer, particularly in its urban populations. The results of this trial will be applicable to large numbers of people and could demonstrate differences in breast cancer that aren't found elsewhere.

"We also hope that this is just the first in many research collaborations with Chinese cancer centres. We have much to learn about these diseases and by working with on this scale we can get scientific answers more quickly."

The trial is being run in conjunction with the Breast International Group, which facilitates cooperation in large breast cancer trials. It is funded by a one million Hong Kong dollar donation by the W & E Davies Charitable Foundation.

Source: University of Edinburgh

Explore further: Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

Related Stories

Quest for better breast cancer drugs

Nov 27, 2006

Breast cancer sufferers could eventually benefit from high-tuned, tailor-made drug treatments that minimize side effects as a result of a joint initiative between computer scientists in Edinburgh and cellular biologists in ...

Adding radiation decreases breast cancer recurrence

Jan 22, 2007

Radiotherapy after breast conserving surgery for breast cancer reduces recurrence and prevents development of additional breast tumors in older women with early stage breast disease, according to a new study. Published in ...

No need for gene screens in breast cancer families

Jul 23, 2008

Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a ...

Recommended for you

Spicy treatment the answer to aggressive cancer?

Jul 03, 2015

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.